CNE100003M51
CNE100003M51
GUANGDONG MARUBI BIOTECHNOLOGY
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 3.459.318.084 | 2.969.770.567 | 16.5% |
| Cost of Revenue | 889.519.268 | 781.028.905 | 13.9% |
| Gross Profit | 2.569.798.816 | 2.188.741.661 | 17.4% |
| 2.315.890.401 | 1.828.856.143 | 26.6% | |
| Operating Income | 253.908.414 | 359.885.518 | 29.4% |
| Pretax Income | 295.731.445 | 380.656.509 | 22.3% |
| Net Income Common Stockholders | 247.239.141 | 341.628.708 | 27.6% |
| -- | -- | -- | |
| -- | -- | -- |